Enanta Pharmaceuticals

World Rank (Jan-05-2024)

16,659

Market Cap (Jan-05-2024)

0.254 Billion USD

World Rank (Jul-30-2023)

14,315

Market Cap (Jul-30-2023)

0.388 Billion USD

World Rank (Jan-07-2022)

7,749

Market Cap (Jan-07-2022)

1.398 Billion USD

World Rank (Jan-01-2021)

8,668

Market Cap (Jan-01-2021)

0.845 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

ENTA

Market Cap (Mar-08-2026)

0.39

Employee Count

155

Employee Count as of Date

As on 2021

Headquarters City/State

Massachusetts

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

97 Million USD

Annual Net Income in USD

-78 Million USD

Annual Results for Period Ending

Sep-2021 ending year

Total Assets in USD

438 Million USD

Total Liabilities in USD

39 Million USD

Total Equity in USD

399 Million USD

Balance Sheet for Period Ending

Sep-2021 ending year

Business Sector

Company Website

ENANTA PHARMACEUTICALS INC

Yahoo

Yahoo @ Nasdaq

Company Profile

Enanta Pharmaceuticals is a Clinical Stage Biotechnology company. It is a robust chemistry driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for viral infections and liver diseases. The company annual revenue is 205.2 million USD and 132 employees as on 2020. The headquarters is in USA.

IPO Year

2013

Stock Exchange

Nasdaq

Company SubCategory

Top Healthcare Companies in USA

Top Pharmaceutical Companies in USA

Nasdaq Sector

Health Care

Nasdaq Industry

Biotechnology: Pharmaceutical Preparations